Department of Chemistry , Zhejiang University , Hangzhou 310027 , People's Republic of China.
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital , Zhejiang University School of Medicine , Hangzhou , Zhejiang 310009 , People's Republic of China.
Anal Chem. 2019 Jul 16;91(14):9251-9258. doi: 10.1021/acs.analchem.9b02144. Epub 2019 Jun 25.
Qualitative and quantitative analysis of -glycans by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is hampered mainly by the low ionization efficiency of analytes and their poor cocrystallization with traditional organic acid matrices. In the present study, a ombination trategy of eactive and atalytic atrices (CSRCM) was proposed for the on-target derivatization and detection of reducing -glycans: a novel reactive matrix, , 2,5-dihydroxybenzohydrazide (DHBH), having a skeleton structure similar to that of DHB, was designed and synthesized, and this reactive matrix was mixed with catalytic matrix DHB to form a rationally combinatorial matrix (DHB/DHBH). Qualitatively, DHB/DHBH could improve the ionization efficiency of reducing carbohydrates significantly. Quantitatively, the acid-base chemistry of DHB/DHBH leads to a uniform cocrystallization of analytes-matrix mixtures. Consequently, CSRCM provides accurate quantitation for -glycans with high derivatization efficiency and good linearity ( > 0.99) within 2 orders of magnitude on the basis of an internal standard method. Furthermore, the CSRCM was successfully applied to evaluating -glycan in serum samples of colorectal cancer patients, thus showing potential in clinical applications for biomarker discovery.
基质辅助激光解吸/电离质谱(MALDI-MS)对 -聚糖进行定性和定量分析主要受到分析物低的离子化效率和与传统有机酸基质差的共结晶的阻碍。在本研究中,提出了一种反应性和催化性基质(CSRCM)的组合策略,用于靶向衍生化和检测还原 -聚糖:设计并合成了一种新型反应性基质,即 2,5-二羟基苯甲酰肼(DHBH),其骨架结构与 DHB 相似,该反应性基质与催化基质 DHB 混合形成合理组合的基质(DHB/DHBH)。定性地,DHB/DHBH 可以显著提高还原碳水化合物的离子化效率。定量地,DHB/DHBH 的酸碱化学导致分析物-基质混合物的均匀共结晶。因此,基于内标法,CSRCM 为 -聚糖提供了高效衍生化和良好线性(>0.99)的 2 个数量级的准确定量。此外,CSRCM 成功应用于评估结直肠癌患者血清样本中的 -聚糖,因此在生物标志物发现的临床应用中具有潜力。